A multivalent biparatopic EGFR-targeting nanobody drug conjugate displays potent anticancer activity in solid tumor models.

ABSTRACT:

SUBMITTER: Fan J 

PROVIDER: S-EPMC8413295 | biostudies-literature | 2021 Sep

REPOSITORIES: biostudies-literature